BREAKING NEWS: Aqueous announces new technology to enhance human tear production
AQUEOUS PHARMA
Aqueous Pharma was founded by Joe Echols so the innovative products developed by Dr Frank Holly would be available to the millions of suffering and unsatisfied dry eye patients, worldwide.
Human Tear Film Protects Ocular Surface
NutraTear, Dakrina & Dwelle were launched in 2005 by The Dry Eye Company LLC, for the USA.
A Development company dedicated to innovative therapy for Dry Eye Syndrome.
Artificial Tears are the mainstay therapy for Dry Eye Syndrome.
FreshKote was launched in the USA by FOCUS Labs on May 1, 2006.
Each product was developed by the esteemed Dr. Frank Holly and are the only artificial tears that are not only tear substitutes, but address the underlying cause of Dry Eye.
In the process of commercializing FreshKote (code name: APL-105) on a global basis via out-licensing. This product will be sold under various other brand names due to language and cultural differences.
